Variant report

Variant	esv3381101
Chromosome Location	chr20:22548552-22551550
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:25)
CpG islands
(count:306)
Chromatin interactive
region (count:2)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:25 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr20:22549197-22549508	H1-hESC	embryonic stem cell:	n/a	n/a
2	BATF	chr20:22550565-22550746	GM12878	blood:	n/a	chr20:22550638-22550649
3	BHLHE40	chr20:22550704-22550708	K562	blood:	n/a	n/a
4	CTBP2	chr20:22548308-22549987	H1-hESC	embryonic stem cell:	n/a	n/a
5	CUX1	chr20:22551421-22551817	K562	blood:	n/a	chr20:22551732-22551746
6	E2F6	chr20:22549055-22549571	H1-hESC	embryonic stem cell:	n/a	chr20:22549157-22549169 chr20:22549462-22549469 chr20:22549462-22549473
7	E2F6	chr20:22549079-22549442	H1-hESC	embryonic stem cell:	n/a	chr20:22549157-22549169
8	EGR1	chr20:22549468-22549810	H1-hESC	embryonic stem cell:	n/a	n/a
9	FOS	chr20:22550606-22550837	MCF10A-Er-Src	breast:	n/a	n/a
10	POLR2A	chr20:22550459-22550935	H1-neurons	neurons:	n/a	n/a
11	POLR2A	chr20:22548858-22548882	HepG2	liver:	n/a	n/a
12	POLR2A	chr20:22549913-22550466	H1-neurons	neurons:	n/a	n/a
13	POLR2A	chr20:22551130-22551321	MCF10A-Er-Src	breast:	n/a	n/a
14	POLR2A	chr20:22551416-22553266	HepG2	liver:	n/a	n/a
15	POLR2A	chr20:22548261-22548719	HepG2	liver:	n/a	n/a
16	POLR2A	chr20:22550562-22550980	H1-neurons	neurons:	n/a	n/a
17	POLR2A	chr20:22549476-22550403	H1-neurons	neurons:	n/a	n/a
18	POLR2A	chr20:22548319-22548630	H1-hESC	embryonic stem cell:	n/a	n/a
19	RCOR1	chr20:22548667-22548807	K562	blood:	n/a	n/a
20	SIN3A	chr20:22548975-22549268	H1-hESC	embryonic stem cell:	n/a	n/a
21	SP1	chr20:22548529-22548990	H1-hESC	embryonic stem cell:	n/a	chr20:22548581-22548595 chr20:22548582-22548591 chr20:22548575-22548584 chr20:22548580-22548592 chr20:22548581-22548591 chr20:22548581-22548590 chr20:22548580-22548592 chr20:22548917-22548926 chr20:22548573-22548585 chr20:22548963-22548973 chr20:22548574-22548588 chr20:22548574-22548584 chr20:22548915-22548927 chr20:22548915-22548927 chr20:22548963-22548973
22	STAT3	chr20:22550461-22550806	MCF10A-Er-Src	breast:	n/a	n/a
23	SUZ12	chr20:22548639-22549785	H1-hESC	embryonic stem cell:	n/a	n/a
24	SUZ12	chr20:22547785-22550361	NT2-D1	testis:	n/a	n/a
25	TBP	chr20:22548633-22549215	H1-hESC	embryonic stem cell:	n/a	n/a

(count:306 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr20:22549719-22549769	AG09309	skin:	n/a
2	chr20:22549719-22549769	AG09309	skin:	n/a
3	chr20:22550129-22550179	PANC-1	pancreas:	n/a
4	chr20:22549361-22549411	HRCEpiC	kidney:	n/a
5	chr20:22549124-22549174	GM12891	blood:	n/a
6	chr20:22549719-22549769	GM12878	blood:	n/a
7	chr20:22550129-22550179	CMK	blood:	n/a
8	chr20:22549361-22549411	HCPEpiC	choroid plexus:	n/a
9	chr20:22549253-22549303	HUVEC	blood vessel:	n/a
10	chr20:22549361-22549411	AG09309	skin:	n/a
11	chr20:22549361-22549411	GM12891	blood:	n/a
12	chr20:22549253-22549303	ECC-1	luminal epithelium:	n/a
13	chr20:22549719-22549769	NH-A	brain:	n/a
14	chr20:22549361-22549411	LNCaP	prostate:	n/a
15	chr20:22549124-22549174	NB4	blood:	n/a
16	chr20:22549361-22549411	HCM	heart:	n/a
17	chr20:22550129-22550179	T-47D	breast:	n/a
18	chr20:22550129-22550179	GM19239	blood:	n/a
19	chr20:22549253-22549303	HCM	heart:	n/a
20	chr20:22550129-22550179	AoSMC	blood vessel:	n/a
21	chr20:22549361-22549411	BJ	skin:	n/a
22	chr20:22549253-22549303	GM12892	blood:	n/a
23	chr20:22549361-22549411	GM06990	blood:	n/a
24	chr20:22549253-22549303	T-47D	breast:	n/a
25	chr20:22549719-22549769	Hepatocyte	liver:	n/a
26	chr20:22549124-22549174	HMEC	breast:	n/a
27	chr20:22549719-22549769	AG04450	lung:	fetal
28	chr20:22549719-22549769	GM19239	blood:	n/a
29	chr20:22549124-22549174	SK-N-SH	brain:	n/a
30	chr20:22549253-22549303	IMR90	lung:	fetal
31	chr20:22549719-22549769	MCF-7	breast:	n/a
32	chr20:22549719-22549769	AG10803	skin:	n/a
33	chr20:22549719-22549769	PrEC	prostate:	n/a
34	chr20:22549719-22549769	H1-hESC	embryonic stem cell:	embryo
35	chr20:22549253-22549303	HNPCEpiC	eye:	n/a
36	chr20:22549361-22549411	RPTEC	kidney:	n/a
37	chr20:22549361-22549411	HUVEC	blood vessel:	n/a
38	chr20:22550129-22550179	ECC-1	luminal epithelium:	n/a
39	chr20:22549253-22549303	SK-N-SH_RA	brain:	n/a
40	chr20:22550129-22550179	HEEpiC	esophagus:	n/a
41	chr20:22549253-22549303	SKMC	muscle:	n/a
42	chr20:22549124-22549174	A549	lung:	n/a
43	chr20:22549253-22549303	HPAEpiC	pulmonary alveolar:	n/a
44	chr20:22550129-22550179	HUVEC	blood vessel:	n/a
45	chr20:22549719-22549769	ovcar-3	ovarian:	n/a
46	chr20:22549253-22549303	HepG2	liver:	n/a
47	chr20:22550129-22550179	HL-60	blood:	n/a
48	chr20:22549719-22549769	AG09319	gingival:	n/a
49	chr20:22550129-22550179	IMR90	lung:	fetal
50	chr20:22550129-22550179	HPAEpiC	pulmonary alveolar:	n/a

(count:2 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr20:22537625..22541473-chr20:22546828..22550085,4	MCF-7	breast:
2	chr20:22423238..22424747-chr20:22550793..22553587,2	K562	blood:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-FOXA2-2	chr20:22548432-22548833	NONHSAT078994

No data

Variant related genes	Relation type
LINC00261	TF binding region
LINC00261	CpG island

Extended variants
information (count: 127 )
Associated
traits (count: 56 )

Variant overlapped rSNPs/rCNVs (count:127 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs559737756	chr20:22548570-22548571	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Genic enhancers Enhancers Weak transcription Strong transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
2	rs531959041	chr20:22548578-22548579	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Genic enhancers Enhancers Weak transcription Strong transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
3	rs552085668	chr20:22548583-22548584	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Genic enhancers Enhancers Weak transcription Strong transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
4	rs374809496	chr20:22548585-22548586	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Genic enhancers Enhancers Weak transcription Strong transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
5	rs568798765	chr20:22548587-22548588	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Genic enhancers Enhancers Weak transcription Strong transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
6	rs6137689	chr20:22548602-22548603	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Genic enhancers Active TSS Weak transcription Enhancers Flanking Active TSS Strong transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
7	rs114607340	chr20:22548645-22548646	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Genic enhancers Active TSS Weak transcription Enhancers Flanking Active TSS Strong transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
8	rs370425617	chr20:22548691-22548692	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Genic enhancers Active TSS Weak transcription Enhancers Flanking Active TSS Strong transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
9	rs73089875	chr20:22548693-22548694	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Genic enhancers Active TSS Weak transcription Enhancers Flanking Active TSS Strong transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
10	rs932560	chr20:22548698-22548699	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Genic enhancers Active TSS Weak transcription Enhancers Flanking Active TSS Strong transcription	TF binding region lncRNA	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs567973864	chr20:22548731-22548732	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Genic enhancers Active TSS Weak transcription Enhancers Flanking Active TSS Strong transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
12	rs548608204	chr20:22548733-22548734	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Genic enhancers Active TSS Weak transcription Enhancers Flanking Active TSS Strong transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
13	rs187152552	chr20:22548762-22548763	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Genic enhancers Active TSS Weak transcription Enhancers Flanking Active TSS Strong transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
14	rs570889604	chr20:22548765-22548766	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Genic enhancers Active TSS Weak transcription Enhancers Flanking Active TSS Strong transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
15	rs80088930	chr20:22548768-22548769	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Genic enhancers Active TSS Weak transcription Enhancers Flanking Active TSS Strong transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
16	rs556937021	chr20:22548869-22548870	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Genic enhancers Active TSS Flanking Active TSS Enhancers Weak transcription Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs576672467	chr20:22548889-22548890	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Genic enhancers Active TSS Flanking Active TSS Enhancers Weak transcription Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs542112280	chr20:22548894-22548895	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Genic enhancers Active TSS Flanking Active TSS Enhancers Weak transcription Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs568774964	chr20:22548935-22548936	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Genic enhancers Active TSS Flanking Active TSS Enhancers Weak transcription Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs572517894	chr20:22548959-22548960	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Genic enhancers Active TSS Flanking Active TSS Enhancers Weak transcription Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs540350726	chr20:22549030-22549031	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Genic enhancers Active TSS Enhancers Weak transcription Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs559800334	chr20:22549040-22549041	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Genic enhancers Active TSS Enhancers Weak transcription Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs532016948	chr20:22549077-22549078	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Genic enhancers Active TSS Enhancers Weak transcription Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs545389220	chr20:22549129-22549130	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Genic enhancers Active TSS Enhancers Weak transcription Strong transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
25	rs376509325	chr20:22549141-22549142	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Genic enhancers Active TSS Enhancers Weak transcription Strong transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
26	rs550151655	chr20:22549147-22549148	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Genic enhancers Active TSS Enhancers Weak transcription Strong transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
27	rs11087387	chr20:22549179-22549180	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Genic enhancers Active TSS Enhancers Weak transcription Strong transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
28	rs531641471	chr20:22549191-22549192	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Genic enhancers Active TSS Enhancers Weak transcription Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs548153662	chr20:22549209-22549210	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Active TSS Enhancers Strong transcription Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs373474293	chr20:22549213-22549214	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Active TSS Enhancers Strong transcription Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs1203893	chr20:22549221-22549222	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Active TSS Enhancers Strong transcription Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
32	rs191136211	chr20:22549238-22549239	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Active TSS Enhancers Strong transcription Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs547945855	chr20:22549243-22549244	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Active TSS Enhancers Strong transcription Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs374819895	chr20:22549324-22549325	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Active TSS Enhancers Strong transcription Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs570949034	chr20:22549346-22549347	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Active TSS Enhancers Strong transcription Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs1203894	chr20:22549369-22549370	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Active TSS Enhancers Strong transcription Weak transcription	TF binding region CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
37	rs11087388	chr20:22549437-22549438	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Strong transcription Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs556032920	chr20:22549445-22549446	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Strong transcription Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs569914873	chr20:22549458-22549459	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Strong transcription Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs373749490	chr20:22549474-22549475	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Strong transcription Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs536167307	chr20:22549481-22549482	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Strong transcription Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs376713504	chr20:22549533-22549534	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Strong transcription Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs148923590	chr20:22549595-22549596	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Strong transcription Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs533852323	chr20:22549605-22549606	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Weak transcription Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs541214054	chr20:22549613-22549614	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Weak transcription Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs555587256	chr20:22549620-22549621	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Weak transcription Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs573847725	chr20:22549634-22549635	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Weak transcription Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs147695113	chr20:22549647-22549648	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Weak transcription Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs544661033	chr20:22549677-22549678	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Weak transcription Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs562857719	chr20:22549721-22549722	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Weak transcription Strong transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:56)

Disease	PMID	Source
Wilms tumour	21544195	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	16272173	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Oral cancer	19627613	CNVD
colon cancer	17210682	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	21080181	CNVD
Thyroid cancer	19087340	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Colorectal cancer	19359472	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Human rectal carcinomas	16397240	CNVD
Olfactory neuroblastoma	18408657	CNVD
Central neurocytomas	17123091	CNVD
Colorectal cancer	16272173	CNVD
Medulloblastoma	21979893	CNVD
Gastric cancer	17908304	CNVD
Urothelial carcinoma	21177765	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Colorectal cancer	21645411	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Autism	22495311	CNVD
Renal cell carcinoma	18765545	CNVD
Alagille syndrome	17576883	CNVD
Anaplastic large cell lymphoma	18179710	CNVD
Prostate cancer	18632612	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Cancer	21183584	CNVD
Myxofibrosarcoma	16751306	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Breast cancer	16608533	CNVD
Cancer	20164919	CNVD
Bladder cancer	21909424	CNVD
Esophageal cancer	21851588	CNVD
Breast cancer	17133270	CNVD
Thrombophilia	17576883	CNVD
Myelofibrosis	22110671	CNVD
Mental retardation	21062444	CNVD
Hepatocellular carcinoma	22174799	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Chordoma	18071362	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD

Chromatin state (count:135 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr20:22540000-22548800	Weak transcription	Gastric	stomach
2	chr20:22544600-22549400	Genic enhancers	Liver	Liver
3	chr20:22545600-22548600	Weak transcription	Pancreas	Pancrea
4	chr20:22546600-22548800	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
5	chr20:22547000-22550800	Strong transcription	HepG2	liver
6	chr20:22547200-22549000	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
7	chr20:22547800-22549800	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
8	chr20:22548000-22548600	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
9	chr20:22548000-22548600	Enhancers	Pancreatic Islets	Pancreatic Islet
10	chr20:22548000-22549000	Enhancers	K562	blood
11	chr20:22548000-22549200	Weak transcription	Rectal Mucosa Donor 31	rectum
12	chr20:22548200-22548800	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
13	chr20:22548200-22549000	Transcr. at gene 5' and 3'	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
14	chr20:22548400-22548600	Bivalent Enhancer	Stomach Mucosa	stomach
15	chr20:22548400-22548800	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
16	chr20:22548400-22549000	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
17	chr20:22548400-22549400	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
18	chr20:22548400-22549400	Flanking Bivalent TSS/Enh	HUES48 Cell Line	embryonic stem cell
19	chr20:22548400-22549800	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
20	chr20:22548400-22549800	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
21	chr20:22548600-22548800	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
22	chr20:22548600-22548800	Bivalent Enhancer	Duodenum Smooth Muscle	Duodenum
23	chr20:22548600-22548800	Flanking Active TSS	Pancreas	Pancrea
24	chr20:22548600-22548800	Flanking Bivalent TSS/Enh	Stomach Mucosa	stomach
25	chr20:22548600-22548800	Bivalent Enhancer	HSMMtube	muscle
26	chr20:22548600-22549400	Flanking Bivalent TSS/Enh	HUES64 Cell Line	embryonic stem cell
27	chr20:22548600-22549400	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
28	chr20:22548600-22549600	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell
29	chr20:22548600-22549600	Enhancers	Lung	lung
30	chr20:22548600-22550400	Active TSS	Pancreatic Islets	Pancreatic Islet
31	chr20:22548800-22549000	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
32	chr20:22548800-22549000	Flanking Bivalent TSS/Enh	ES-UCSF4 Cell Line	embryonic stem cell
33	chr20:22548800-22549000	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
34	chr20:22548800-22549000	Bivalent Enhancer	Brain Cingulate Gyrus	brain
35	chr20:22548800-22549000	Bivalent Enhancer	Brain Dorsolateral Prefrontal Cortex	brain
36	chr20:22548800-22549000	Flanking Active TSS	Gastric	stomach
37	chr20:22548800-22549200	Bivalent Enhancer	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
38	chr20:22548800-22549200	Bivalent Enhancer	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
39	chr20:22548800-22549200	Bivalent Enhancer	Right Ventricle	heart
40	chr20:22548800-22549200	Bivalent Enhancer	Stomach Mucosa	stomach
41	chr20:22548800-22549400	Bivalent/Poised TSS	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
42	chr20:22548800-22549400	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
43	chr20:22548800-22549400	Flanking Bivalent TSS/Enh	iPS DF 19.11 Cell Line	embryonic stem cell
44	chr20:22548800-22549400	Bivalent Enhancer	Fetal Muscle Trunk	muscle
45	chr20:22548800-22549400	Bivalent Enhancer	Fetal Muscle Leg	muscle
46	chr20:22548800-22549600	Bivalent Enhancer	iPS DF 6.9 Cell Line	embryonic stem cell
47	chr20:22548800-22549600	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
48	chr20:22548800-22549600	Bivalent Enhancer	Spleen	Spleen
49	chr20:22548800-22549800	Bivalent Enhancer	Colonic Mucosa	Colon
50	chr20:22548800-22549800	Bivalent Enhancer	Skeletal Muscle Female	skeletal muscle

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links